This study does have limitations, namely the use of two cell models imperfectly representing CLL, the variability in CLL sample purity and limited number of available patients to investigate the correlation between UGT2B17 expression levels and PGE2 response in detail. Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.